Bastion Asset Management Inc. acquired a new stake in shares of Neogen Corporation (NASDAQ:NEOG – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund acquired 246,729 shares of the company’s stock, valued at approximately $1,736,000.
Several other large investors also recently made changes to their positions in NEOG. Cresset Asset Management LLC bought a new position in shares of Neogen during the 2nd quarter valued at about $53,000. Evergreen Capital Management LLC acquired a new position in shares of Neogen in the second quarter worth about $56,000. Osaic Holdings Inc. boosted its holdings in shares of Neogen by 183.5% in the second quarter. Osaic Holdings Inc. now owns 12,663 shares of the company’s stock worth $61,000 after buying an additional 8,196 shares during the period. Tudor Investment Corp ET AL acquired a new position in shares of Neogen in the third quarter worth about $62,000. Finally, Coldstream Capital Management Inc. acquired a new position in shares of Neogen in the third quarter worth about $64,000. Institutional investors own 96.73% of the company’s stock.
Neogen Price Performance
NASDAQ NEOG opened at $8.35 on Wednesday. The company has a 50 day moving average price of $9.21 and a two-hundred day moving average price of $8.61. The company has a quick ratio of 2.84, a current ratio of 3.92 and a debt-to-equity ratio of 0.38. Neogen Corporation has a 12-month low of $4.53 and a 12-month high of $11.43. The stock has a market capitalization of $1.82 billion, a PE ratio of -2.98, a price-to-earnings-growth ratio of 3.72 and a beta of 1.84.
Analyst Ratings Changes
Several research analysts have commented on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Neogen in a report on Friday, April 10th. Wall Street Zen upgraded shares of Neogen from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Finally, William Blair restated a “market perform” rating on shares of Neogen in a report on Monday, March 2nd. Two investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Neogen currently has a consensus rating of “Hold” and an average price target of $10.67.
Read Our Latest Stock Report on Neogen
About Neogen
Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.
In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.
Featured Stories
- Five stocks we like better than Neogen
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Corporation (NASDAQ:NEOG – Free Report).
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.
